| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Australian economic evaluation and government decisions on pharmaceuticals, compared to assessment of other health technologies
|
Hailey, David
|
|
1997
|
45 |
4 |
p. 563-581
19 p.
|
artikel
|
| 2 |
Conclusions and implications
|
Sloan, Frank A
|
|
1997
|
45 |
4 |
p. 645-647
3 p.
|
artikel
|
| 3 |
Economic evaluation in support of national health policy: The case of the Netherlands
|
Elsinga, Einte
|
|
1997
|
45 |
4 |
p. 605-620
16 p.
|
artikel
|
| 4 |
Economic evaluation of medical technologies: From theory to practice—The German perspective
|
Von Der Schulenburg, J.-Matthias Graf
|
|
1997
|
45 |
4 |
p. 621-633
13 p.
|
artikel
|
| 5 |
Economic evaluation of medical technologies in Sweden
|
Jönsson, Bengt
|
|
1997
|
45 |
4 |
p. 597-604
8 p.
|
artikel
|
| 6 |
Economic evaluation under managed competition: Evidence from the U.K.
|
Drummond, Michael
|
|
1997
|
45 |
4 |
p. 583-595
13 p.
|
artikel
|
| 7 |
Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysis
|
Sloan, Frank A
|
|
1997
|
45 |
4 |
p. 523-533
11 p.
|
artikel
|
| 8 |
Introduction and overview
|
Sloan, Frank A
|
|
1997
|
45 |
4 |
p. 505-510
6 p.
|
artikel
|
| 9 |
Making economic evaluations respectable
|
Reinhardt, Uwe E
|
|
1997
|
45 |
4 |
p. 555-562
8 p.
|
artikel
|
| 10 |
Managed care pharmacy, socioeconomic assessments and drug adoption decisions
|
Lyles, Alan
|
|
1997
|
45 |
4 |
p. 511-521
11 p.
|
artikel
|
| 11 |
Pharmaceutical economy and the economic assessment of drugs in France
|
Pen, Claude Le
|
|
1997
|
45 |
4 |
p. 635-643
9 p.
|
artikel
|
| 12 |
Pharmacy benefit management, cost-effectiveness analysis and drug formulary decisions
|
Grabowski, Henry
|
|
1997
|
45 |
4 |
p. 535-544
10 p.
|
artikel
|
| 13 |
The Oregon experiment: The role of cost-benefit analysis in the allocation of Medicaid funds
|
Blumstein, James F
|
|
1997
|
45 |
4 |
p. 545-554
10 p.
|
artikel
|
Tijdschrift beschrijving